Tag: CRISPR/Cas9

  • Nation & World

    Veteran biotech executive to run new center aimed at boosting cell and gene therapies

    Landmark Bio, a new center for advanced cell manufacturing, announced that former Orchard Therapeutics, Amgen, and Genzyme executive Ran Zheng will take over as chief executive. Landmark Bio is a partnership of Boston-area universities, hospitals, and private industry led by Harvard and MIT.

    5 minutes
    Ran Zheng,
  • Nation & World

    From one, many

    Harvard research teams systematically profiled every cell in developing zebrafish and frog embryos to establish a roadmap revealing how one cell builds an entire organism.

    12 minutes
  • Nation & World

    A shot against heart attacks?

    Harvard Stem Cell Institute scientists collaborating with researchers at the University of Pennsylvania have developed a “genome-editing” approach for permanently reducing cholesterol levels in mice through a single injection, a development with the potential to reduce the risk of heart attacks in humans by 40 to 90 percent.

    6 minutes